Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Billion dollar babies--biotech drugs as blockbusters.

Literature DB >> 17420735

Billion dollar babies--biotech drugs as blockbusters.

Stacy Lawrence.

Abstract

Mesh：

Substances：

Year: 2007 PMID： 17420735 DOI： 10.1038/nbt0407-380

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Alkyne- and 1,6-elimination- succinimidyl carbonate - terminated heterobifunctional poly(ethylene glycol) for reversible "Click" PEGylation.

Authors: Yumei Xie; Shaofeng Duan; M Laird Forrest
Journal: Drug Discov Ther Date: 2010

2. Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.

Authors: Arutselvan Natarajan; Frezghi Habte; Sanjiv S Gambhir
Journal: Bioconjug Chem Date: 2012-06-11 Impact factor: 4.774

Review 3. Animal pharming, two decades on.

Authors: Alexander Kind; Angelika Schnieke
Journal: Transgenic Res Date: 2008-07-29 Impact factor: 2.788

Review 4. Immuno-positron emission tomography in cancer models.

Authors: Smitha Reddy; Matthew K Robinson
Journal: Semin Nucl Med Date: 2010-05 Impact factor: 4.446

5. The role of means and goals in technology acceptance. A differentiated landscape of public perceptions of pharming.

Authors: Rafael Pardo; Margret Engelhard; Kristin Hagen; Rikke Bagger Jørgensen; Eckard Rehbinder; Angelika Schnieke; Mariana Szmulewicz; Felix Thiele
Journal: EMBO Rep Date: 2009-09-18 Impact factor: 8.807

6. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.

Authors: Thijs J Giezen; Aukje K Mantel-Teeuwisse; Ronald H B Meyboom; Sabine M J M Straus; Hubert G M Leufkens; Toine C G Egberts
Journal: Drug Saf Date: 2010-10-01 Impact factor: 5.606

Billion dollar babies--biotech drugs as blockbusters.

1. Alkyne- and 1,6-elimination- succinimidyl carbonate - terminated heterobifunctional poly(ethylene glycol) for reversible "Click" PEGylation.

2. Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.

Review 3. Animal pharming, two decades on.

Review 4. Immuno-positron emission tomography in cancer models.

5. The role of means and goals in technology acceptance. A differentiated landscape of public perceptions of pharming.

6. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.

7. The effect of protein structure on their controlled release from an injectable peptide hydrogel.

Review 8. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

9. Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels.

10. Solvatochromism as a new tool to distinguish structurally similar compounds.